23 results
Keyword Neostigmine Remove keyword
-
List item
Human medicine European public assessment report (EPAR): Bridion
sugammadex, Neuromuscular Blockade
Date of authorisation: 25/07/2008, Revision: 20, Authorised, Last updated: 14/02/2022Bridion was compared with neostigmine (another medicine used to … mg/kg Bridion with that of neostigmine after deep relaxation of … Bridion was more effective than neostigmine in reducing the time it took … -
List item
Human medicine European public assessment report (EPAR): Firdapse (previously Zenas)
amifampridine, Lambert-Eaton Myasthenic Syndrome
Date of authorisation: 23/12/2009,
, 
, Revision: 21, Authorised, Last updated: 25/05/2022
-
List item
Human medicine European public assessment report (EPAR): Sialanar
glycopyrronium bromide, Sialorrhea
Date of authorisation: 15/09/2016, Revision: 8, Authorised, Last updated: 20/04/2022 -
List item
Human medicine European public assessment report (EPAR): Vantobra (previously Tobramycin PARI)
Tobramycin, Respiratory Tract Infections; Cystic Fibrosis
Date of authorisation: 18/02/2019, Revision: 3, Authorised, Last updated: 13/04/2021 -
List item
Human medicine European public assessment report (EPAR): Sugammadex Mylan
sugammadex sodium, Neuromuscular Blockade
Date of authorisation: 15/11/2021,
, Authorised, Last updated: 22/11/2021
-
List item
Human medicine European public assessment report (EPAR): Cresemba
isavuconazole, Aspergillosis
Date of authorisation: 15/10/2015,
, Revision: 13, Authorised, Last updated: 07/12/2021
-
List item
Human medicine European public assessment report (EPAR): Tobi Podhaler
Tobramycin, Cystic Fibrosis; Respiratory Tract Infections
Date of authorisation: 20/07/2011,, Revision: 19, Authorised, Last updated: 13/05/2022
-
List item
Human medicine European public assessment report (EPAR): Emend
Aprepitant, Vomiting; Postoperative Nausea and Vomiting; Cancer
Date of authorisation: 11/11/2003, Revision: 28, Authorised, Last updated: 28/09/2021 -
List item
Human medicine European public assessment report (EPAR): Balaxur
memantine hydrochloride, donepezil hydrochloride, Alzheimer Disease
Date of refusal: 20/02/2013, Refused, Last updated: 11/03/2013 -
List item
Human medicine European public assessment report (EPAR): Acrescent
memantine hydrochloride, donepezil hydrochloride, Alzheimer Disease
Date of refusal: 20/02/2013, Refused, Last updated: 11/03/2013 -
List item
Referral: Intravenous nicardipine medicines
nicardipine, associated names: Cardene IV, Loxen, Nicardipine Aguettant, Nicardipine Arrow, Rydene, Vasonase, Article 31 referrals
Status: European Commission final decision, opinion/position date: 24/10/2013, EC decision date: 20/12/2013, Last updated: 12/03/2014 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 10-13 May 2016
European Medicines Agency, London, UK, from 10/05/2016 to 13/05/2016, Last updated: 13/03/2014 -
List item
European network of paediatric research-European Medicines Agency meeting on rare gastrointestinal and liver diseases
European Medicines Agency, London, UK, 08/12/2015, Last updated: 26/01/2016 -
List item
Public data from Article 57 database
Last updated: 02/06/2021 -
List item
Veterinary Medicines - Availability (minor uses/minor species)
Last updated: 31/12/2009 -
List item
News: Feedback requested on the draft list of EU reference dates for periodic safety update reports in preparation for introduction of the new pharmacovigilance legislation
Last updated: 04/04/2012 -
List item
Periodic safety update reports (PSURs)
Last updated: 09/07/2021 -
List item
Guidance documents
Last updated: 14/09/2021 -
List item
Needs for paediatric medicines
Last updated: 11/05/2016formulation GLYCOPYRROLATE + NEOSTIGMINE Authorised indication Control …
-
List item
Periodic safety update reports
Last updated: 26/09/2018 -
List item
PRAC: meeting archive 2015-2017
Last updated: 13/05/2016 -
List item
News: European Medicines Agency to begin PSUR assessment based on active substances in both centrally and nationally authorised medicines
Last updated: 27/03/2013 -
List item
News: European Medicines Agency publishes list of EU reference dates and frequency of PSUR submission
Last updated: 01/10/2012